Latest Market Research Report 2025

  The global   virtual clinical trials market   was valued at   USD 8.75 billion in 2023, and it is projected to expand at a   compound annual growth rate (CAGR) of 5.7%   from   2024 to 2030. This growth is primarily attributed to the   increase in research and development (R&D) activities, the   digitization of the healthcare industry, and the widespread   adoption of telehealth solutions. Furthermore, the market is being propelled by rapid   technological advancements, growing   collaborations between clinical research organizations (CROs), pharmaceutical firms, and biotechnology companies, as well as   supportive regulatory and governmental initiatives. The   COVID-19 pandemic   served as a major inflection point for the industry, as it necessitated a shift from traditional, site-based clinical trials to more   flexible, remote, and technology-enabled trial models, thereby accelerating the adoption o...

  Virtual Clinical Trials Industry Overview The global  virtual clinical trials market  size is expected to reach USD 12.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.7% from 2022 to 2030. The COVID-19 pandemic has significantly impacted the market. The growing need for patient diversity clubbed with enhanced data collection in clinical trials is boosting the market growth.   Virtual Clinical Trials Market Segmentation Grand View Research has segmented the global virtual clinical trials market based on study design, indication, and region:   Based on the Study Design Insights, the market is segmented into Interventional, Observational, and Expanded Access. The interventional design segment led the Virtual/Decentralized Clinical Trials (DCTs) market and accounted for the largest revenue share of 46.7% in 2021. The rapid increase in the number of experiments to develop no...